2DL-28416-29787
5 vaccinations
2 coded responses
53 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 402 / KY
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Dose 1 — Pfizer-BioNTech
-
2021-02-17
Dose 2 — Pfizer-BioNTech
-
2021-02-18
Registered in v-safe
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · HeadacheAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-24
- 2021-03-05
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-05-21
- 2021-08-18
-
2021-08-21
Dose 3 — Pfizer-BioNTech
-
2021-08-21
Health check-in — day 0, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-22
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-08-23
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Itching · NauseaAdult check-in
- 2021-08-27
-
2021-08-28
Health check-in — day 7, dose 3Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-04
- 2021-09-11
- 2021-09-18
- 2021-09-25
-
2021-10-02
Survey response — day 42, dose 3MedDRA: Cough, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Low fever, cough, congestionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-22
- 2021-12-08
- 2022-02-19
-
2022-02-28
Dose 4 — Pfizer-BioNTech
-
2022-03-01
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-03-02
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-03-03
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-03-04
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2022-03-04
Report sent to call center — days 1–6 daily, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-03-05
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-03-06
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-03-07
-
2022-03-07
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-03-14
- 2022-03-21
- 2022-03-28
- 2022-04-04
- 2022-04-11
- 2022-05-30
- 2022-08-29
-
2022-09-10
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-13
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-16
- 2022-09-17
- 2022-09-24
- 2022-10-01
- 2022-10-08
- 2022-10-15
- 2022-10-22
- 2022-12-10
- 2023-03-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-17 | Pfizer-BioNTech | |
| 3 | 2021-08-21 | Pfizer-BioNTech | No |
| 4 | 2022-02-28 | Pfizer-BioNTech | No |
| 5 | 2022-09-10 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-02 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-03-04 | Successful 2022-03-07 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Dizziness
Release 9 — day 42, dose 3
Symptoms: Low fever, cough, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Dizziness | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release